Legacy Lifepoint Health 10-Q 1 May 15 2015 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2015	Apr. 24, 2015
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Entity Registrant Name	LIFEPOINT HOSPITALS, INC.
Entity Central Index Key	1301611
Current Fiscal Year End Date	-19
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		44,308,133
Trading Symbol	LPNT

Condensed_Consolidated_Stateme

Condensed Consolidated Statements Of Operations (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Condensed Consolidated Statements Of Operations [Abstract]
Revenues before provision for doubtful accounts	$1,451.60	$1,182.80
Provision for doubtful accounts	187.9	175.6
Revenues	1,263.70	1,007.20
Salaries and benefits	611.2	474.8
Supplies	196.8	157
Other operating expenses	293.6	243.5
Other income	-11.7	-13.9
Depreciation and amortization	68	61.1
Interest expense, net	28.4	33.9
Impairment charges	11.6
Operating expenses, total	1,197.90	956.4
Income before income taxes	65.8	50.8
Provision for income taxes	23.8	13.1
Net income	42	37.7
Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests	-3.1	-0.6
Net income attributable to LifePoint Hospitals, Inc.	$38.90	$37.10
Earnings per share attributable to LifePoint Hospitals, Inc. stockholders:
Basic	$0.88	$0.81
Diluted	$0.84	$0.78
Weighted average shares and dilutive securities outstanding:
Basic	44.1	45.9
Diluted	46.1	47.8

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Millions, unless otherwise specified
Current assets:
Cash and cash equivalents	$281.90	$191.50
Accounts receivable, less allowances for doubtful accounts of $708.1 and $709.5 at March 31, 2015 and December 31, 2014, respectively	747.5	752.6
Inventories	114.1	115.2
Prepaid expenses	48.8	45.4
Income taxes receivable	25	33
Deferred tax assets	64.4	72.8
Other current assets	89.7	85.7
Total current assets	1,371.40	1,296.20
Property and equipment:
Land	131.9	134.8
Buildings and improvements	2,176.30	2,155.90
Equipment	1,594.70	1,633.80
Construction in progress (estimated costs to complete and equip after March 31, 2015 is $107.0)	69.2	72.9
Property and equipment, gross	3,972.10	3,997.40
Accumulated depreciation	-1,648.70	-1,619.90
Property and equipment, net	2,323.40	2,377.50
Deferred loan costs, net	30.4	31.7
Intangible assets, net	71.7	69.1
Other assets	61.2	46.4
Goodwill	1,633.30	1,636.10
Total assets	5,491.40	5,457
Current liabilities:
Accounts payable	158	158.5
Accrued salaries	169.9	202.4
Other current liabilities	246.2	203.2
Current maturities of long-term debt	22	19.2
Total current liabilities	596.1	583.3
Long-term debt	2,192.80	2,199.30
Deferred income tax liabilities	191.4	187.5
Long-term portion of reserves for self-insurance claims	137.5	133.2
Other long-term liabilities	82.1	84.7
Total liabilities	3,199.90	3,188
Redeemable noncontrolling interests	89.2	87.1
Equity:
Preferred stock, $0.01 par value; 10,000,000 shares authorized; no shares issued
Common stock, $0.01 par value; 90,000,000 shares authorized; 66,469,722 and 66,245,310 shares issued at March 31, 2015 and December 31, 2014, respectively	0.7	0.7
Capital in excess of par value	1,511.60	1,496.20
Accumulated other comprehensive loss	-4.4	-4.4
Retained earnings	1,512	1,473.10
Common stock in treasury, at cost, 22,165,439 and 21,672,250 shares at March 31, 2015 and December 31, 2014, respectively	-844.8	-811
Total LifePoint Hospitals, Inc. stockholders' equity	2,175.10	2,154.60
Noncontrolling interests	27.2	27.3
Total equity	2,202.30	2,181.90
Total liabilities and equity	$5,491.40	$5,457

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Millions, except Share data, unless otherwise specified
Condensed Consolidated Balance Sheets [Abstract]
Accounts receivable, allowances for doubtful accounts	$708.10	$709.50
Estimated cost to complete and equip	$107
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	90,000,000	90,000,000
Common stock, shares issued	66,469,722	66,245,310
Common stock in treasury, shares	22,165,439	21,672,250

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements Of Cash Flows (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net income	$42	$37.70
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	7.6	6.7
Depreciation and amortization	68	61.1
Amortization of physician minimum revenue guarantees	3.2	3.9
Amortization of debt discounts, premium and deferred loan costs	1.2	7.3
Impairment charges	11.6
Deferred income taxes (benefit)	12.3	-41.6
Reserve for self-insurance claims, net of payments	4.1	6.1
Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures:
Accounts receivable	6.2	-50.5
Inventories, prepaid expenses and other current assets	14.1	23.1
Accounts payable, accrued salaries and other current liabilities	4	-0.3
Income taxes payable/receivable	8	52.5
Other	-2.7	2.6
Net cash provided by operating activities	179.6	108.6
Cash flows from investing activities:
Purchases of property and equipment	-41.1	-22.5
Acquisitions, net of cash acquired	-13.3	-60.6
Other	0.2	-0.5
Net cash used in investing activities	-54.2	-83.6
Cash flows from financing activities:
Payments of borrowings	-2.8
Repurchases of common stock	-33.8	-135.8
Proceeds from exercise of stock options	7	7.2
Other	-5.4	-2
Net cash (used in) provided by financing activities	-35	-130.6
Change in cash and cash equivalents	90.4	-105.6
Cash and cash equivalents at beginning of period	191.5	637.9
Cash and cash equivalents at end of period	281.9	532.3
Supplemental disclosure of cash flow information:
Interest payments	4.5	3.7
Capitalized interest	0.4	0.2
Income tax payments, net	$3.60	$2.30

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements Of Stockholders' Equity (USD $)	Common Stock [Member]	Capital In Excess Of Par Value [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Noncontrolling Interests [Member]	Total
In Millions
Balance at Dec. 31, 2014	$0.70	$1,496.20	($4.40)	$1,473.10	($811)	$27.30	$2,181.90
Balance, shares at Dec. 31, 2014	44.6
Net income				38.9		1.2	40.1
Exercise of stock options, tax benefits of stock-based awards and other		7					7
Exercise of stock options, tax benefits of stock-based awards and other, shares	0.2
Stock-based compensation		7.6					7.6
Repurchases of common stock, at cost					-33.8		-33.8
Repurchases of common stock, at cost, shares	-0.5
Noncash change in noncontrolling interests as a result of acquisition and other		0.8				-0.7	0.1
Cash distributions to noncontrolling interests						-0.6	-0.6
Balance at Mar. 31, 2015	$0.70	$1,511.60	($4.40)	$1,512	($844.80)	$27.20	$2,202.30
Balance, shares at Mar. 31, 2015	44.3

Organization_Basis_Of_Presenta

Organization, Basis Of Presentation And Accounting Standards Not Yet Adopted	3 Months Ended
	Mar. 31, 2015
Organization, Basis Of Presentation And Accounting Standards Not Yet Adopted [Abstract]
Organization, Basis Of Presentation And Accounting Standards Not Yet Adopted	Note 1. Organization, Basis of Presentation and Accounting Standards Not Yet Adopted
	Organization
	LifePoint Hospitals, Inc., a Delaware corporation, acting through its subsidiaries, operates general acute care hospitals primarily in non-urban communities in the United States (“U.S.”). Unless the context otherwise indicates, LifePoint Hospitals, Inc. and its subsidiaries are referred to herein as the “Company.” At March 31, 2015, on a consolidated basis, the Company operated 65 hospital campuses in 21 states.
	Basis of Presentation
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, and disclosures considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.
	Additionally, the accompanying unaudited condensed consolidated financial statements include the accounts of the Company and all subsidiaries and entities controlled by the Company through its direct or indirect ownership of a majority interest and exclusive rights granted to the Company as the sole general partner or controlling member of such entities, including Duke LifePoint Healthcare, a joint venture between LifePoint and a wholly-controlled affiliate of Duke University Health System, Inc.  Furthermore, the Company consolidates any entities for which it receives the majority of the entity’s expected returns or is at risk for the majority of the entity’s expected losses based upon its investment or financial interest in the entity.  All significant intercompany accounts and transactions within the Company have been eliminated in consolidation.
	Accounting Standards Not Yet Adopted
	ASU 2015-2, “Consolidation”
	In February 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-2 “Consolidation” (“ASU 2015-2”).  ASU 2015-2 includes amendments that are intended to improve targeted areas of consolidation for legal entities including reducing the number of consolidation models from four to two and simplifying the FASB Accounting Standards Codification (“ASC”).  The provisions of ASU 2015-2 are effective for annual periods beginning after December 15, 2015.  The amendments may be applied retrospectively in previously issued financial statements for one or more years with a cumulative effect adjustment to retained earnings as of the beginning of the first year restated. Early adoption is permitted.  The Company is currently evaluating the impact that the adoption of ASU 2015-2 will have on its financial position, results of operation, cash flows and financial disclosures.
	ASU 2014-9, “Revenue from Contracts with Customers”
	In May 2014, the FASB issued ASU 2014-9, “Revenue from Contracts with Customers” (“ASU 2014-9”).  ASU 2014-9 provides for a single comprehensive principles-based standard for the recognition of revenue across all industries through the application of the following five-step process:
	Step 1: Identify the contract(s) with a customer.
	Step 2: Identify the performance obligations in the contract.
	Step 3: Determine the transaction price.
	Step 4: Allocate the transaction price to the performance obligations in the contract.
	Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
	Among other provisions and in addition to expanded disclosure about the nature, amount, timing and uncertainty of revenue, as well as certain additional quantitative and qualitative disclosures, ASU 2014-9 changes the healthcare industry specific presentation guidance under ASU 2011-7, “Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities.”  The provisions of ASU 2014-9 are effective for annual periods beginning after December 15, 2016, including interim periods within those years.    Early adoption is not permitted. The Company is currently evaluating the impact that the adoption of ASU 2014-9 will have on its revenue recognition policies and procedures, financial position, results of operations, cash flows, financial disclosures and control framework.

Revenue_Recognition_And_Accoun

Revenue Recognition And Accounts Receivable	3 Months Ended
	Mar. 31, 2015
Revenue Recognition And Accounts Receivable [Abstract]
Revenue Recognition And Accounts Receivable	Note 2. Revenue Recognition and Accounts Receivable
	The Company recognizes revenues in the period in which services are performed. Accounts receivable primarily consist of amounts due from third-party payors and patients. The Company’s ability to collect outstanding receivables is critical to its results of operations and cash flows.  Amounts the Company receives for treatment of patients covered by governmental programs such as Medicare and Medicaid and other third-party payors such as health maintenance organizations (“HMOs”), preferred provider organizations (“PPOs”) and other private insurers are generally less than the Company’s established billing rates.  Additionally, to provide for accounts receivable that could become uncollectible in the future, the Company establishes an allowance for doubtful accounts to reduce the carrying value of such receivables to their estimated net realizable value.  Accordingly, the revenues and accounts receivable reported in the accompanying unaudited condensed consolidated financial statements are recorded at the net amount expected to be received.
	The Company’s revenues before provision for doubtful accounts by payor and approximate percentages of revenues were as follows for the three months ended March 31, 2015 and 2014 (in millions):
		Three Months Ended March 31,
		2015				2014
				% of				% of
		Amount		Revenues		Amount		Revenues
	Medicare	$	377.9	29.9	%	$	316.8	31.5	%
	Medicaid		197.4	15.6			140.2	13.9
	HMOs, PPOs and other private insurers		681.1	53.9			536.6	53.2
	Self-pay		164.3	13.0			167.2	16.6
	Other		30.9	2.5			22.0	2.2
	Revenues before provision for doubtful accounts		1,451.6	114.9			1,182.8	117.4
	Provision for doubtful accounts		-187.9	-14.9			-175.6	-17.4
	Revenues	$	1,263.7	100.0	%	$	1,007.2	100.0	%
	The primary uncertainty of the Company’s accounts receivable lies with uninsured patient receivables and deductibles, co-payments or other amounts due from individual patients.  The Company has an established process to determine the adequacy of the allowance for doubtful accounts that relies on a number of analytical tools and benchmarks to arrive at a reasonable allowance. No single statistic or measurement determines the adequacy of the allowance for doubtful accounts. Some of the analytical tools that the Company utilizes include, but are not limited to, historical cash collection experience, revenue trends by payor classification and revenue days in accounts receivable.  Accounts receivable are written off after collection efforts have been followed in accordance with the Company’s policies.
	The following is a summary of the Company’s activity in the allowance for doubtful accounts for the three months ended March 31, 2015 (in millions):
	Balance at January 1, 2015	$	709.5
	Additions recognized as a reduction to revenues		187.9
	Accounts written off, net of recoveries		-189.3
	Balance at March 31, 2015	$	708.1
	The allowances for doubtful accounts as a percent of gross accounts receivable, net of contractual discounts were 48.6% and 48.5% as of March 31, 2015 and December 31, 2014, respectively. Additionally, as of March 31, 2015 and December 31, 2014, the allowances for doubtful accounts plus certain contractual allowances and discounts related to self-pay patients as a percentage of self-pay receivables were 88.0% and 88.4%, respectively.

General_And_Administrative_Cos

General And Administrative Costs	3 Months Ended
	Mar. 31, 2015
General And Administrative Costs [Abstract]
General And Administrative Costs	Note 3. General and Administrative Costs
	The majority of the Company’s expenses are “cost of revenue” items. Costs that could be classified as “general and administrative” by the Company would include its hospital support center overhead costs, which were $53.9 million and $52.2 million for the three months ended March 31, 2015 and 2014, respectively. Included in the Company’s hospital support center overhead costs are depreciation and amortization expense related primarily to the Company’s information systems platforms of $8.1 million and $7.3 million for the three months ended March 31, 2015 and 2014, respectively.

Fair_Value_Of_Financial_Instru

Fair Value Of Financial Instruments	3 Months Ended
	Mar. 31, 2015
Fair Value Of Financial Instruments [Abstract]
Fair Value Of Financial Instruments	Note 4. Fair Value of Financial Instruments
	In accordance with ASC 825-10, “Financial Instruments” and ASC 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), the fair value of the Company’s financial instruments are further described as follows.
	Cash and Cash Equivalents, Accounts Receivable and Accounts Payable
	The carrying amounts reported in the accompanying unaudited condensed consolidated balance sheets for cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the short-term maturity of these instruments.
	Long-Term Debt
	The carrying amounts and fair values of the Company’s senior secured term loan facility (the “Term Facility”) and senior secured incremental term loans (the “Incremental Term Loans”) under its senior secured credit agreement with, among others, Citibank, N.A. as administrative agent, and the lenders party thereto (the “Senior Credit Agreement”), 6.625%  unsecured senior notes due October 1, 2020 (the “6.625% Senior Notes”), and 5.5% unsecured senior notes due December 1, 2021 (the “5.5% Senior Notes”) as of March 31, 2015 and December 31, 2014 were as follows (in millions):
		Carrying Amount				Fair Value
		March 31,		December 31,		March 31,		December 31,
		2015		2014		2015		2014
	Senior Credit Agreement:
	Term Facility	$	419.1	$	421.9	$	417.0	$	420.3
	Incremental Term Loans, excluding unamortized debt discount	$	222.6	$	222.6	$	222.6	$	222.0
	6.625% Senior Notes	$	400.0	$	400.0	$	420.5	$	422.0
	5.5% Senior Notes, excluding unamortized debt premium	$	1,100.0	$	1,100.0	$	1,152.3	$	1,130.3
	The fair values of the Company’s long-term debt instruments were estimated based on the average bid and ask price as determined using published rates and categorized as Level 2 within the fair value hierarchy in accordance with ASC 820-10.
	Common Stock Warrant
	As partial consideration in connection with the Company’s acquisition of Conemaugh Health System (“Conemaugh”), the Company issued a warrant to the seller.  The warrant, classified as a liability, is marked-to-market using an option pricing model which considers the warrant’s contractual term, a combination of both historical volatility and implied volatility from traded options of the Company’s common stock, risk-free interest rates and dividend assumptions.  Since all significant inputs are market-based and observable, the warrant is categorized as Level 2 within the fair value hierarchy in accordance with ASC 820-10.  As of March 31, 2015 and December 31, 2014, the fair value of the warrant was approximately $8.5 million and $9.2 million, respectively. These amounts are included in the accompanying unaudited condensed consolidated balance sheets under the caption “Other long-term liabilities”.

Acquisitions

Acquisitions	3 Months Ended
	Mar. 31, 2015
Acquisitions [Abstract]
Acquisitions	Note 5. Acquisitions
	Nason Hospital
	Effective February 1, 2015,  the Company acquired Nason Hospital (“Nason”), a 45 bed acute care hospital located in Roaring Spring,  Pennsylvania for approximately $3.5 million, including net working capital. The Company has committed to invest in Nason an additional $8.5 million in capital expenditures and improvements over the next ten years.  The results of operations of Nason are included in the Company’s results of operations beginning on February 1, 2015. The fair values assigned to certain assets acquired and liabilities assumed in relation to the Company’s acquisition of Nason have been prepared on a preliminary basis with information currently available and are subject to change. Specifically, the Company is further assessing the valuation of certain tangible and intangible assets acquired and obligations assumed pending the final appraisals. The Company expects to finalize its analysis during 2015.
	Ancillary Service-Line Acquisitions
	The Company completed certain ancillary service-line acquisitions, including physician practices, totaling $9.8 million during the three months ended March 31, 2015.

Divestitures_And_Impairment_Ch

Divestitures And Impairment Charges	3 Months Ended
	Mar. 31, 2015
Divestitures And Impairment Charges [Abstract]
Divestitures And Impairment Charges	Note 6. Divestitures and Impairment Charges
	In March 2015, the Company entered into a definitive agreement to sell the assets of Putnam Community Medical Center (“Putnam”) located in Palatka, Florida. The sale closed effective May 1, 2015. Included in the accompanying unaudited condensed consolidated statements of operations is income before income taxes attributable to Putnam of $1.7 million and $2.4 million for the three months ended March 31, 2015 and 2014, respectively. The assets and liabilities that have been classified as held for sale in connection with the Putnam transaction totaled $21.8 million and $2.4 million, respectively, and are included under the captions “Other current assets” and “Other current liabilities” in the accompanying unaudited condensed consolidated balance sheet as of March 31, 2015.
	In connection with the Company’s entry into a definitive agreement to sell the assets of Putnam, the Company recognized an impairment charge of $8.6 million, $5.6 million net of income taxes, or $0.12 loss per diluted share, during the three months ended March 31, 2015. The impairment charge includes the write-down of property, equipment, allocated goodwill and certain other assets to their estimated fair values.
	Additionally, during the three months ended March 31, 2015, the Company recognized additional impairment charges totaling $3.0 million, $1.9 million net of income taxes, or $0.04 loss per diluted share, related to the finalization of the divestitures of Lakeland Community Hospital, Northwest Medical Center and Russellville Hospital which were sold effective January 1, 2015.

Goodwill_And_Intangible_Assets

Goodwill And Intangible Assets	3 Months Ended
	Mar. 31, 2015
Goodwill And Intangible Assets [Abstract]
Goodwill And Intangible Assets	Note 7. Goodwill and Intangible Assets
	Goodwill
	The Company accounts for its acquisitions in accordance with ASC 805-10, “Business Combinations” using the acquisition method of accounting. Goodwill represents the excess of the cost of an acquired entity over the net amounts assigned to assets acquired and liabilities assumed. In accordance with ASC 350-10, “Intangibles — Goodwill and Other” goodwill and intangible assets with indefinite lives are reviewed by the Company at least annually for impairment. The Company’s business comprises a single reporting unit for impairment test purposes. For the purposes of these analyses, the Company’s estimates of fair value are based on a combination of the income approach, which estimates the fair value of the Company based on its future discounted cash flows, and the market approach, which estimates the fair value of the Company based on comparable market prices. The Company performed its most recent annual impairment test as of October 1, 2014 and did not incur an impairment charge.
	Intangible Assets
	Summary of Intangible Assets
	The following table provides information regarding the Company’s intangible assets, which are included in the accompanying unaudited condensed consolidated balance sheets at March 31, 2015 and December 31, 2014 (in millions):
		March 31,		December 31,
		2015		2014
	Amortized intangible assets:
	Contract-based physician minimum revenue guarantees
	Gross carrying amount	$	59.9	$	62.3
	Accumulated amortization		-35.7		-35.5
	Net total		24.2		26.8
	Non-competition agreements and other
	Gross carrying amount		25.0		23.6
	Accumulated amortization		-16.8		-15.9
	Net total		8.2		7.7
	Total amortized intangible assets
	Gross carrying amount		84.9		85.9
	Accumulated amortization		-52.5		-51.4
	Net total		32.4		34.5
	Indefinite-lived intangible assets:
	Certificates of need and certificates of need exemptions		29.7		29.5
	Licenses, provider numbers, accreditations and other		9.6		5.1
	Net total		39.3		34.6
	Total intangible assets:
	Gross carrying amount		124.2		120.5
	Accumulated amortization		-52.5		-51.4
	Net total	$	71.7	$	69.1
	Contract-Based Physician Minimum Revenue Guarantees
	The Company has committed to provide certain financial assistance pursuant to recruiting agreements, or “physician minimum revenue guarantees,” with various physicians practicing in the communities it serves. In consideration for a physician relocating to one of its communities and agreeing to engage in private practice for the benefit of the respective community, the Company may advance certain amounts of money to a physician to assist in establishing his or her practice.
	The Company accounts for its physician minimum revenue guarantees in accordance with the provisions of ASC 460-10, “Guarantees” (“ASC 460-10”). In accordance with ASC 460-10, the Company records a contract-based intangible asset and a related guarantee liability for new physician minimum revenue guarantees. The contract-based intangible asset is amortized over the period of the physician contract, which typically ranges from four to five years and is included as an expense under the caption “Other operating expenses” in the accompanying unaudited condensed consolidated statements of operations. The Company’s liability for contract-based physician minimum revenue guarantees was $9.3 million at both March 31, 2015 and December 31, 2014. These amounts are included in the accompanying unaudited condensed consolidated balance sheets under the caption “Other current liabilities”.
	Non-Competition Agreements
	The Company has entered into non-competition agreements with certain physicians and other individuals which are amortized on a straight-line basis over the term of the agreements.
	Certificates of Need and Certificates of Need Exemptions
	The construction or acquisition of new facilities, the expansion of existing facilities and the addition of new services and certain equipment at the Company’s facilities may be subject to state laws that require prior approval by state regulatory agencies. These certificate of need laws generally require that a state agency determine the public need and give approval prior to the construction or acquisition of facilities or the addition of new services. The Company operates hospitals in certain states that have adopted certificate of need laws.  The Company has determined that these intangible assets have an indefinite useful life.
	Licenses, Provider Numbers, Accreditations and Other
	To operate hospitals, the Company must obtain certain licenses, provider numbers and accreditations from federal, state and other accrediting agencies.  The Company has determined that these intangible assets have an indefinite useful life.

Common_Stock_In_Treasury

Common Stock In Treasury	3 Months Ended
	Mar. 31, 2015
Common Stock In Treasury [Abstract]
Common Stock In Treasury	Note 8. Common Stock in Treasury
	The Company’s Board of Directors has authorized the repurchase of outstanding shares of its common stock either in the open market or through privately negotiated transactions, subject to market conditions, regulatory constraints and other customary factors in accordance with a repurchase plan adopted in 2011, as subsequently amended and extended in February 2013 (the “2011 Repurchase Plan”) and a repurchase plan adopted in 2014 (the “2014 Repurchase Plan”).  The 2011 Repurchase Plan provided for the repurchase of up to $350.0 million in shares of the Company’s common stock, and the Company has repurchased all shares authorized for repurchase under this plan. The 2014 Repurchase Plan provides for the repurchase of up to $150.0 million in shares of the Company’s common stock through October 1, 2015. The Company is not obligated to repurchase any specific number of shares under the 2014 Repurchase Plan.  The Company has designated the shares repurchased in accordance with its repurchase plans as treasury stock.
	In connection with the 2011 Repurchase Plan, the Company repurchased approximately 2.4 million shares for an aggregate purchase price, including commissions, of $128.6 million at an average purchase price of $53.22 per share during the three months ended March 31, 2014.   In connection with the 2014 Repurchase Plan, the Company repurchased approximately 0.4 million shares for an aggregate purchase price, including commissions, of $25.0 million at an average purchase price of $67.86 per share during the three months ended March 31, 2015. As of March 31, 2015, the Company had remaining authority to repurchase $75.0 million in shares in accordance with the 2014 Repurchase Plan.
	Additionally, the Company redeems shares from employees for minimum statutory tax withholding purposes upon vesting of certain stock awards granted pursuant to the Company’s various stockholder approved stock-based compensation plans. The Company redeemed approximately 0.1 million shares vested under these plans during each of the three months ended March 31, 2015 and 2014 for an aggregate purchase price of approximately $8.8 million and $7.2 million, respectively. The Company has designated these shares as treasury stock.

StockBased_Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2015
Stock-Based Compensation [Abstract]
Stock-Based Compensation	Note 9. Stock-Based Compensation
	Overview
	The Company issues stock-based awards, including stock options and other stock-based awards (nonvested stock, restricted stock, restricted stock units and performance shares) to certain officers, employees and non-employee directors in accordance with the Company’s stockholder-approved 2013 Long-Term Incentive Plan (the “2013 LTIP”). The Company accounts for its stock-based awards in accordance with the provisions of ASC 718-10, “Compensation – Stock Compensation” (“ASC 718-10”), and accordingly recognizes compensation expense over each of the stock-based award’s requisite service period based on the estimated grant date fair value.
	Notwithstanding the specific grant vesting requirements, award agreements under the 2013 LTIP may provide for accelerated vesting in certain circumstances.  Generally, award agreements provide for full vesting upon the death or disability of the participant.  Some award agreements also provide for partial or full vesting upon involuntary termination of employment, provided that if the award is performance-based then the accelerated vesting would occur only if the performance goals are attained.
	Stock Options
	The Company granted options to purchase 816,750 and 712,950 shares of the Company’s common stock to certain officers and employees in accordance with the 2013 LTIP during the three months ended March 31, 2015 and 2014, respectively.  Options to purchase shares granted to the Company’s officers and employees in accordance with the 2013 LTIP were granted with an exercise price equal to the fair market value of the Company’s common stock on the day of grant, determined based on the closing price on the trading date immediately prior to the grant date. The options granted during the three months ended March 31, 2015 and 2014 become ratably exercisable beginning one year from the date of grant to three years after the date of grant and expire ten years from the date of grant.
	The Company estimated the fair value of stock options granted using the Hull-White II (“HW-II”) lattice option valuation model and a single option award approach.  The Company uses HW-II because it considers characteristics of fair value option pricing, such as an option’s contractual term and the probability of exercise before the end of the contractual term.  In addition, the complications surrounding the expected term of an option are material, as indicated in ASC 718-10.  Given the Company’s relatively large pool of unexercised options, the Company believes a lattice model that specifically addresses this fact and models a full term of exercises is the most appropriate and reliable means of valuing its stock options.  The Company is amortizing the fair value on a straight-line basis over the requisite service period of the awards, which is the vesting period of three years.  The stock options vest 33.3% on each grant anniversary date over three years of continued employment.
	The following table shows the weighted average assumptions the Company used to develop the fair value estimates under its HW-II option valuation model and the resulting estimates of weighted-average fair value per share of stock options granted during the three months ended March 31, 2015 and 2014:
		Three Months Ended March 31,
		2015				2014
	Expected volatility		29.0	%			29.0	%
	Risk-free interest rate, minimum		0.02	%			0.05	%
	Risk-free interest rate, maximum		1.96	%			2.71	%
	Expected dividends		-				-
	Average expected term (years)		5.3				5.4
	Fair value per share of stock options granted	$	18.65			$	13.95
	The total intrinsic value of stock options exercised during the three months ended March 31, 2015 and 2014 was $4.5 million and $2.7 million, respectively. The Company received $7.0 million and $7.2 million in cash from stock option exercises for the three months ended March 31, 2015 and 2014, respectively. The actual tax benefit realized for the tax deductions from stock option exercises was nominal for the three months ended March 31, 2015 and 2014.
	As of March 31, 2015, there was $20.3 million of total estimated unrecognized compensation cost related to stock option compensation arrangements. Total estimated unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. The Company expects to recognize that cost over a weighted average period of 1.7 years.
	Other Stock-Based Awards
	The Company granted a total of 256,216 and 341,155 restricted stock units and performance-based restricted stock units to certain officers and employees in accordance with the 2013 LTIP during the three months ended March 31, 2015 and 2014, respectively.  The fair value of the restricted stock units was determined based on the closing price of the Company’s common stock on the trading date immediately prior to the grant date.  The fair value of the performance-based restricted stock units was estimated using the Monte-Carlo simulation valuation model as more fully described below. The restricted stock units and performance-based restricted stock units granted during the three months ended March 31, 2015 and 2014 have either cliff-vesting periods from the grant date of three years or ratable vesting periods beginning one year from the date of grant to three years after the date of grant.
	Of the restricted stock units granted during the three months ended March 31, 2015 and 2014, 145,000 and 236,000, respectively, were performance-based awards.  In addition to requiring continuing service of the employee, the percentage of these restricted stock units that are earned at the end of the performance period is determined based on the Company’s three-year annualized total shareholder return relative to a peer group, Standard and Poor’s Global Industry Classification Standard’s Sub-industry:  Health Care Facilities with over $500.0 million in revenues or its equivalent. For the performance-based restricted stock units granted during the three months ended March 31, 2015, the number of shares payable at the end of the three-year performance period ranges from 0% to 200% of the targeted units.  For the performance-based restricted stock units granted during the three months ended March 31, 2014, the number of shares payable at the end of the three-year performance period ranges from 0% to 100% of the targeted units, with any portion of the award that exceeds 100% up to 200% of the targeted units settled in cash equal to the fair market value on the date certification of the level of performance is achieved.  For valuation purposes, these awards were bifurcated into their two independent sub-award components for the portion that would be settled in the Company’s common stock and for the portion that would be settled in cash.  The Company recognizes compensation expense for the portion of the performance-based restricted stock units that will ultimately be settled in the Company’s common stock for the targeted units if the requisite service period is rendered, even if the market condition is never satisfied.  Additionally, the Company classifies as a liability and recognizes compensation expense for the portion of the award that will ultimately be settled in cash for the targeted units at its Monte-Carlo simulation value which has been marked-to-market.
	As of March 31, 2015,  there was $35.2 million of total estimated unrecognized compensation cost related to other stock-based awards. Total estimated unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. The Company expects to recognize that cost over a weighted average period of 2.0 years.
	The following table summarizes the Company’s total stock-based compensation expense as well as the total recognized tax benefits related thereto for the three months ended March 31, 2015 and 2014 (in millions):
		Three Months Ended
		March 31,
		2015			2014
	Equity awards:
	Other stock-based awards	$	4.7		$	4.3
	Stock options		2.9			2.4
			7.6			6.7
	Liability awards:
	Other stock-based awards		0.7			0.2
	Total stock-based compensation expense	$	8.3		$	6.9
	Tax benefit on stock-based compensation expense	$	3.3		$	2.7
	The Company did not capitalize any stock-based compensation cost during the three months ended March 31, 2015 or 2014. As of March 31, 2015, there was $55.5 million of total estimated unrecognized compensation cost related to all of the Company’s stock-based compensation arrangements. Total estimated unrecognized compensation cost may be adjusted for future changes in estimated forfeitures. The Company expects to recognize that cost over a weighted-average period of 1.9 years.

Commitments_And_Contingencies

Commitments And Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments And Contingencies [Abstract]
Commitments And Contingencies	Note 10. Commitments and Contingencies
	Legal Proceedings and General Liability Claims
	Hospitals are, from time to time, subject to claims and suits arising in the ordinary course of business, including claims for damages for personal injuries, medical malpractice, breach of contracts, wrongful restriction of or interference with physicians’ staff privileges and employment related claims. In certain of these actions, plaintiffs request payment for damages, including punitive damages that may not be covered by insurance.
	In addition, hospitals are subject to the regulation and oversight of various state and federal governmental agencies. Further, under the federal False Claims Act, private parties have the right to bring qui tam, or “whistleblower,” suits against hospitals that submit false claims for payments to, or improperly retain overpayments from, governmental payors. Some states have adopted similar state whistleblower and false claims provisions. These qui tam or “whistleblower” actions initiated under the civil False Claims Act may be pending but placed under seal by the court to comply with the False Claims Act’s requirements for filing such suits. As a result, they could be proceeding without the Company’s knowledge. Although the healthcare industry has seen numerous ongoing investigations related to compliance and billing practices, hospitals, in particular, continue to be a primary enforcement target for the Office of Inspector General (“OIG”), the Department of Justice (“DOJ”) and other governmental fraud and abuse programs. Certain of the Company’s individual facilities have received, and from time to time, other facilities may receive, inquiries or subpoenas from fiscal intermediaries, federal and state agencies. Any proceedings against the Company may involve potentially substantial amounts as well as the possibility of civil, criminal, or administrative fines, penalties, or other sanctions, which could be material. Settlements of suits involving Medicare and Medicaid issues routinely require both monetary payments as well as corporate integrity agreements. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material adverse effect on the Company’s financial position, results of operations and liquidity.
	The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 imposed an affirmative obligation on healthcare providers to report and refund any overpayments received. “Overpayments” in this context include any amount received from a government program by a provider to which it is not entitled, regardless of the cause. Such overpayments are deemed to be fraudulent and become violations of the False Claims Act if not reported and refunded within the later of 60 days of identification or the date any corresponding cost report is due (if applicable). Hospitals can meet the obligation to report and refund in three ways: (1) refunding overpayments directly to the program; (2) self-disclosing the overpayment to the OIG via its voluntary self-disclosure protocol (with respect to False Claims Act and other violations not related to the Stark law); and (3) self-disclosing to the Centers for Medicare and Medicaid Services (“CMS”) via the self-referral disclosure protocol (with respect to overpayments caused by potential violations of the Stark law only) for which CMS has the authority to reduce the amounts otherwise owed.
	In connection with the Company’s acquisitions of Marquette General Hospital (“Marquette General”) and Conemaugh, the two sellers self-disclosed various potentially non-compliant physician arrangements under the CMS voluntary self-disclosure protocol.  These self-disclosures are pending with CMS.  With respect to Marquette General, to the extent that the seller’s satisfaction of its retained liabilities, including those under its CMS voluntary self-disclosure, causes its net proceeds from the acquisition to be less than $15.0 million, the Company has agreed to pay additional purchase consideration to the seller.  With respect to Conemaugh, to the extent that the potential settlement exceeds the seller’s indemnification threshold in accordance with the asset purchase agreement, the Company will likely be responsible for funding any deficit.  The Company’s management believes it has made reasonable estimates of its potential exposure for these two matters and at March 31, 2015 has recorded a reserve for Marquette General of $18.0 million.
	On September 16, 2013, the Company and two of its hospitals, Vaughan Regional Medical Center, located in Selma, Alabama, and Raleigh General Hospital, located in Raleigh, West Virginia, made a voluntary self-disclosure to the Civil Division of the DOJ. The voluntary self-disclosure related to concerns regarding the clinical appropriateness of certain interventional cardiology procedures conducted by one physician in each of these hospitals’ cardiac catheterization laboratories.  On September 24, 2013, the U.S. Attorney’s Office in the Southern District of West Virginia served a subpoena on Raleigh General Hospital. Raleigh General Hospital produced responsive documents to the subpoena, including patient files. The government investigations are ongoing and the Company continues to cooperate with the government in addressing these matters. Following reviews by independent interventional cardiologists, the Company notified patients of these two physicians who may have received an unnecessary procedure of such fact.
	The Company and/or Vaughan Regional Medical Center and several of the Company’s subsidiaries, as well as Dr. Seydi V. Aksut and certain parties unaffiliated with the Company, are named defendants in 17 individual lawsuits filed since December 2014, and two putative class action lawsuits, all filed in the Circuit Court of Dallas County, Alabama.  These lawsuits allege that patients at Vaughan Regional Medical Center received improper interventional cardiology procedures.  One of the putative class action lawsuits, filed on November 21, 2014, seeks certification of a class consisting of all Alabama citizens who underwent an invasive cardiology procedure at any LifePoint owned Alabama hospital and who received notice regarding the medical necessity of that procedure.  The other putative class action lawsuit, filed on February 6, 2015, seeks certification of a class of individuals that underwent an interventional cardiology procedure that was not medically necessary and performed by Dr. Aksut.  This action asserts, among other claims, claims under the Racketeer Influenced and Corrupt Organizations Act (“RICO”), which, if successful, would result in the awarding of treble damages for any injury resulting from the RICO violation and attorneys’ fees.  In March 2015, the Company removed this action to the U.S. District Court in Mobile, Alabama and filed a motion to dismiss and for summary judgment, as well as a stay of discovery pending resolution of these motions. On April 17, 2015 the court entered an order granting the requested stay of discovery.
	Through April 24, 2015, six plaintiffs have notified Raleigh General Hospital that they intend to file lawsuits against the hospital.
	The lawsuits identified above variously seek compensatory and punitive damages, costs, attorneys’ fees and other available damages.  Additional claims, including claims involving patients to whom the Company did not send notice, have been threatened and may be asserted against the Company or the hospital.  Any present or future claims that are ultimately successful could result in the Company and/or the hospitals being found liable and the government investigations may also result in damages, fines and penalties. Such liability, damages and penalties could be material. The Company cannot, however, reasonably estimate the potential liability, if any, in connection with any of these matters, and no liability has been recorded as of March 31, 2015.
	The Company does not control and cannot predict with certainty the progress or final outcome of discussions with government agencies, investigations and legal proceedings against the Company.  Therefore, the final amounts paid to resolve the foregoing matters could be material and could materially differ from amounts currently recorded, if any.  Any such changes in the Company’s estimates or any adverse judgments will impact the Company’s future results of operations and cash flows.
	Physician Commitments
	The Company has committed to provide certain financial assistance pursuant to recruiting agreements with various physicians practicing in the communities it serves.  In consideration for a physician’s relocating to one of its communities and agreeing to engage in private practice for the benefit of the respective community, the Company may advance certain amounts of money to a physician, normally over a period of one year, to assist in establishing the physician’s practice.  The Company has committed to advance a maximum amount of approximately $22.4 million at March 31, 2015.  The actual amount of such commitments to be subsequently advanced to physicians is estimated at $9.3 million and often depends upon the financial results of a physician’s private practice during the guarantee period. Generally, amounts advanced under the recruiting agreements may be forgiven pro rata over a period of 36 to 48 months contingent upon the physician continuing to practice in the respective community.  Pursuant to the Company’s standard physician recruiting agreement, any breach or non-fulfillment by a physician under the physician recruiting agreement gives the Company the right to recover any payments made to the physician under the agreement.  Additionally, the Company is subject to annual commitments for certain physician recruiting activities, including the continuation of existing or initiation of new activities with several of its facilities.
	Capital Expenditure Commitments
	The Company is reconfiguring some of its hospitals to more effectively accommodate patient services and to provide for a greater variety of services, as well as implementing various information system initiatives in its efforts to comply with the Health Information Technology for Economic and Clinical Health Act. The Company has incurred approximately $69.2 million in costs related to uncompleted projects as of March 31, 2015, which is included under the caption “Construction in progress” in the accompanying unaudited condensed consolidated balance sheet. At March 31, 2015, these uncompleted projects had an estimated cost to complete and equip of approximately $107.0 million.  Additionally, the Company is subject to annual capital expenditure commitments in connection with several of its facilities.  As part of the Company’s current acquisition strategy, management expects capital expenditure commitments to be a significant component of future purchase transactions. At March 31, 2015, the Company estimated its total remaining capital expenditure commitments, including commitments for routine projects, to be approximately $1,643.2 million.
	Acquisitions
	The Company has historically acquired businesses with prior operating histories. Acquired businesses may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, medical and general professional liabilities, workers compensation liabilities, previous tax liabilities and unacceptable business practices. Although the Company institutes policies designed to conform practices to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. Although the Company generally seeks to obtain indemnification from prospective sellers covering such matters, there can be no assurance that any such matter will be covered by indemnification, or if covered, that such indemnification will be adequate to cover potential losses and fines.

Earnings_Per_Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Earnings Per Share	Note 11. Earnings Per Share
	The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2015 and 2014 (dollars and shares in millions, except per share amounts):
		Three Months Ended
		March 31,
		2015		2014
	Numerator for basic and diluted earnings per share attributable to
	LifePoint Hospitals, Inc.:
	Net income	$	42.0	$	37.7
	Less: Net income attributable to noncontrolling interests
	and redeemable noncontrolling interests		-3.1		-0.6
	Net income attributable to LifePoint Hospitals, Inc.	$	38.9	$	37.1
	Denominator:
	Weighted average shares outstanding - basic		44.1		45.9
	Effect of dilutive securities:
	Stock options and other stock-based awards		2.0		1.5
	Convertible debt instruments		-		0.4
	Weighted average shares outstanding - diluted		46.1		47.8
	Earnings per share attributable to LifePoint Hospitals, Inc. stockholders:
	Basic	$	0.88	$	0.81
	Diluted	$	0.84	$	0.78
	The Company’s previously outstanding convertible debt instruments have been included in the calculation of diluted earnings per share for the three months ended March 31, 2014 whether or not the contingent requirements were met for conversion when their conversion price was less than the average market price of the Company’s common stock for the period the convertible debt instruments were outstanding. Additionally, certain outstanding stock-based awards have been included in the calculation of diluted earnings per share to the extent they were dilutive for the three months ended March 31, 2015 and 2014.

Guarantor_And_NonGuarantor_Sup

Guarantor And Non-Guarantor Supplementary Information	3 Months Ended
	Mar. 31, 2015
Guarantor And Non-Guarantor Supplementary Information [Abstract]
Guarantor And Non-Guarantor Supplementary Information	Note 12. Guarantor and Non-Guarantor Supplementary Information
	The 6.625% Senior Notes and the 5.5% Senior Notes are jointly and severally guaranteed on an unsecured senior basis by substantially all of the Company’s existing subsidiaries that guarantee the Company’s Senior Credit Agreement. The guarantors are 100% owned by the Company. Additionally, the guarantees are full and unconditional and are subject to customary release provisions as set forth in the agreements for the 6.625% Senior Notes and the 5.5% Senior Notes.
	The condensed consolidating financial information for the parent issuer, 100% owned guarantor subsidiaries, non-guarantor subsidiaries, certain eliminations and the Company is presented below for the three months ended March 31, 2015 and 2014 and as of March 31, 2015 and December 31, 2014.
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Operations
	For the Three Months Ended March 31, 2015
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Revenues before provision for
	doubtful accounts	$	-	$	835.0	$	616.6	$	-	$	1,451.6
	Provision for doubtful accounts		-		115.2		72.7		-		187.9
	Revenues		-		719.8		543.9		-		1,263.7
	Salaries and benefits		8.3		331.3		271.6		-		611.2
	Supplies		-		104.8		92.0		-		196.8
	Other operating expenses		-1.3		178.8		116.1		-		293.6
	Other income		-		-9.8		-1.9		-		-11.7
	Equity in earnings of affiliates		-59.5		-		-		59.5		-
	Depreciation and amortization		-		45.4		22.6		-		68.0
	Interest expense, net		8.6		16.4		3.4		-		28.4
	Impairment charges		-		11.6		-		-		11.6
	Management (income) fees		-		-8.5		8.5		-		-
			-43.9		670.0		512.3		59.5		1,197.9
	Income before income taxes		43.9		49.8		31.6		-59.5		65.8
	Provision for income taxes		5.0		18.8		-		-		23.8
	Net income		38.9		31.0		31.6		-59.5		42.0
	Less:  Net income attributable to
	noncontrolling interests and
	redeemable noncontrolling interests		-		-0.2		-2.9		-		-3.1
	Net income attributable to LifePoint
	Hospitals, Inc.	$	38.9	$	30.8	$	28.7	$	-59.5	$	38.9
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Operations
	For the Three Months Ended March 31, 2014
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Revenues before provision for
	doubtful accounts	$	-	$	838.0	$	344.8	$	-	$	1,182.8
	Provision for doubtful accounts		-		128.3		47.3		-		175.6
	Revenues		-		709.7		297.5		-		1,007.2
	Salaries and benefits		6.9		324.5		143.4		-		474.8
	Supplies		-		102.7		54.3		-		157.0
	Other operating expenses		-		180.7		62.8		-		243.5
	Other income		-		-13.6		-0.3		-		-13.9
	Equity in earnings of affiliates		-56.3		-		-		56.3		-
	Depreciation and amortization		-		45.3		15.8		-		61.1
	Interest expense, net		14.3		17.0		2.6		-		33.9
	Management (income) fees		-		-5.1		5.1		-		-
			-35.1		651.5		283.7		56.3		956.4
	Income before income taxes		35.1		58.2		13.8		-56.3		50.8
	(Benefit) provision for income taxes		-2		15.1		-		-		13.1
	Net income		37.1		43.1		13.8		-56.3		37.7
	Less:  Net income attributable to
	noncontrolling interests and
	redeemable noncontrolling interests		-		-0.2		-0.4		-		-0.6
	Net income attributable to LifePoint
	Hospitals, Inc.	$	37.1	$	42.9	$	13.4	$	-56.3	$	37.1
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Balance Sheets
	31-Mar-15
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	-	$	164.2	$	117.7	$	-	$	281.9
Accounts receivable, net		-		453.6		293.9		-		747.5
Inventories		-		70.9		43.2		-		114.1
Prepaid expenses		-		31.0		17.8		-		48.8
Income taxes receivable		25.0		-		-		-		25.0
Deferred tax assets		64.4		-		-		-		64.4
Other current assets		-		54.1		35.6		-		89.7
		89.4		773.8		508.2		-		1,371.4
Property and equipment:
Land		-		70.8		61.1		-		131.9
Buildings and improvements		-		1,530.1		646.2		-		2,176.3
Equipment		-		1,267.0		327.7		-		1,594.7
Construction in progress		-		51.5		17.7		-		69.2
		-		2,919.4		1,052.7		-		3,972.1
Accumulated depreciation		-		-1,406.00		-242.7		-		-1,648.70
		-		1,513.4		810.0		-		2,323.4
Deferred loan costs, net		30.4		-		-		-		30.4
Intangible assets, net		-		32.1		39.6		-		71.7
Investments in subsidiaries		2,085.9		-		-		-2,085.90		-
Due from subsidiaries		2,349.3		-		-		-2,349.30		-
Other assets		7.2		20.0		34.0		-		61.2
Goodwill		-		1,435.4		197.9		-		1,633.3
Total assets	$	4,562.2	$	3,774.7	$	1,589.7	$	-4,435.20	$	5,491.4
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	-	$	88.3	$	69.7	$	-	$	158.0
Accrued salaries		-		97.7		72.2		-		169.9
Other current liabilities		34.2		123.0		89.0		-		246.2
Current maturities of long-term debt		19.7		0.9		1.4		-		22.0
		53.9		309.9		232.3		-		596.1
Long-term debt		2,131.6		48.9		12.3		-		2,192.8
Due to Parent		-		1,686.4		662.9		-2,349.30		-
Deferred income tax liabilities		191.4		-		-		-		191.4
Long-term portion of reserves for self-insurance claims		-		103.3		34.2		-		137.5
Other long-term liabilities		10.2		25.8		46.1		-		82.1
Total liabilities		2,387.1		2,174.3		987.8		-2,349.30		3,199.9
Redeemable noncontrolling interests		-		-		89.2		-		89.2
Total LifePoint Hospitals, Inc. stockholders' equity		2,175.1		1,598.9		487.0		-2,085.90		2,175.1
Noncontrolling interests		-		1.5		25.7		-		27.2
Total equity		2,175.1		1,600.4		512.7		-2,085.90		2,202.3
Total liabilities and equity	$	4,562.2	$	3,774.7	$	1,589.7	$	-4,435.20	$	5,491.4
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Balance Sheets
December 31, 2014
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	-	$	62.0	$	129.5	$	-	$	191.5
Accounts receivable, net		-		451.4		301.2		-		752.6
Inventories		-		71.3		43.9		-		115.2
Prepaid expenses		0.1		29.1		16.2		-		45.4
Income taxes receivable		33.0		-		-		-		33.0
Deferred tax assets		72.8		-		-		-		72.8
Other current assets		-		53.5		32.2		-		85.7
		105.9		667.3		523.0		-		1,296.2
Property and equipment:
Land		-		70.0		64.8		-		134.8
Buildings and improvements		-		1,542.2		613.7		-		2,155.9
Equipment		-		1,289.9		343.9		-		1,633.8
Construction in progress		-		49.6		23.3		-		72.9
		-		2,951.7		1,045.7		-		3,997.4
Accumulated depreciation		-		-1,398.30		-221.6		-		-1,619.90
		-		1,553.4		824.1		-		2,377.5
Deferred loan costs, net		31.7		-		-		-		31.7
Intangible assets, net		-		34.6		34.5		-		69.1
Investments in subsidiaries		2,025.6		-		-		-2,025.60		-
Due from subsidiaries		2,352.1		-		-		-2,352.10		-
Other assets		6.6		19.4		20.4		-		46.4
Goodwill		-		1,440.5		195.6		-		1,636.1
Total assets	$	4,521.9	$	3,715.2	$	1,597.6	$	-4,377.70	$	5,457.0
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	-	$	90.4	$	68.1	$	-	$	158.5
Accrued salaries		-		130.9		71.5		-		202.4
Other current liabilities		14.5		112.7		76.0		-		203.2
Current maturities of long-term debt		16.9		0.9		1.4		-		19.2
		31.4		334.9		217.0		-		583.3
Long-term debt		2,137.5		49.1		12.7		-		2,199.3
Due to Parent		-		1,634.6		717.5		-2,352.10		-
Deferred income tax liabilities		187.5		-		-		-		187.5
Long-term portion of reserves for self-insurance claims		-		103.1		30.1		-		133.2
Other long-term liabilities		10.9		24.7		49.1		-		84.7
Total liabilities		2,367.3		2,146.4		1,026.4		-2,352.10		3,188.0
Redeemable noncontrolling interests		-		-		87.1		-		87.1
Total LifePoint Hospitals, Inc. stockholders' equity		2,154.6		1,567.0		458.6		-2,025.60		2,154.6
Noncontrolling interests		-		1.8		25.5		-		27.3
Total equity		2,154.6		1,568.8		484.1		-2,025.60		2,181.9
Total liabilities and equity	$	4,521.9	$	3,715.2	$	1,597.6	$	-4,377.70	$	5,457.0
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Statements of Cash Flows
For the Three Months Ended March 31, 2015
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Cash flows from operating activities:
Net income	$	38.9	$	31.0	$	31.6	$	-59.5	$	42.0
Adjustments to reconcile net income to net cash provided
by operating activities:
Equity in earnings of affiliates		-59.5		-		-		59.5		-
Stock-based compensation		7.6		-		-		-		7.6
Depreciation and amortization		-		45.4		22.6		-		68.0
Amortization of physician minimum revenue guarantees		-		2.7		0.5		-		3.2
Amortization of debt discounts, premium and deferred loan costs		1.2		-		-		-		1.2
Impairment charges		-		11.6		-		-		11.6
Deferred income taxes		12.3		-		-		-		12.3
Reserve for self-insurance claims, net of payments		-		-		4.1		-		4.1
Increase (decrease) in cash from operating assets and
liabilities, net of effects of acquisitions and divestitures:
Accounts receivable		-		-0.7		6.9		-		6.2
Inventories, prepaid expenses and other current assets		0.1		19.7		-5.7		-		14.1
Accounts payable, accrued salaries and other current liabilities		19.5		-27.5		12.0		-		4.0
Income taxes payable/receivable		8.0		-		-		-		8.0
Other		-0.7		-2.6		0.6		-		-2.7
Net cash provided by operating activities		27.4		79.6		72.6		-		179.6
Cash flows from investing activities:
Purchases of property and equipment		-		-28.4		-12.7		-		-41.1
Acquisitions, net of cash acquired		-		-4		-9.3		-		-13.3
Other		-0.6		2.8		-2		-		0.2
Net cash used in investing activities		-0.6		-29.6		-24		-		-54.2
Cash flows from financing activities:
Payments of borrowings		-2.8		-		-		-		-2.8
Repurchases of common stock		-33.8		-		-		-		-33.8
Proceeds from exercise of stock options		7.0		-		-		-		7.0
Change in intercompany balances with affiliates, net		2.8		51.8		-54.6		-		-
Other		-		0.4		-5.8		-		-5.4
Net cash (used in) provided by financing activities		-26.8		52.2		-60.4		-		-35
Change in cash and cash equivalents		-		102.2		-11.8		-		90.4
Cash and cash equivalents at beginning of period		-		62.0		129.5		-		191.5
Cash and cash equivalents at end of period	$	-	$	164.2	$	117.7	$	-	$	281.9
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Statements of Cash Flows
For the Three Months Ended March 31, 2014
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Cash flows from operating activities:
Net income	$	37.1	$	43.1	$	13.8	$	-56.3	$	37.7
Adjustments to reconcile net income to net cash provided
by operating activities:
Equity in earnings of affiliates		-56.3		-		-		56.3		-
Stock-based compensation		6.7		-		-		-		6.7
Depreciation and amortization		-		45.3		15.8		-		61.1
Amortization of physician minimum revenue guarantees		-		3.6		0.3		-		3.9
Amortization of debt discounts and deferred loan costs		7.3		-		-		-		7.3
Deferred income tax benefit		-41.6		-		-		-		-41.6
Reserve for self-insurance claims, net of payments		-		3.3		2.8		-		6.1
Increase (decrease) in cash from operating assets and
liabilities, net of effects of acquisitions and divestitures:
Accounts receivable		-		-32.2		-18.3		-		-50.5
Inventories, prepaid expenses and other current assets		0.1		23.8		-0.8		-		23.1
Accounts payable, accrued salaries and other current liabilities		21.7		-28.5		6.5		-		-0.3
Income taxes payable/receivable		52.5		-		-		-		52.5
Other		-0.1		1.3		1.4		-		2.6
Net cash provided by operating activities		27.4		59.7		21.5		-		108.6
Cash flows from investing activities:
Purchases of property and equipment		-		-15.7		-6.8		-		-22.5
Acquisitions, net of cash acquired		-		-2.7		-57.9		-		-60.6
Other		-0.8		-0.6		0.9		-		-0.5
Net cash used in investing activities		-0.8		-19		-63.8		-		-83.6
Cash flows from financing activities:
Repurchases of common stock		-135.8		-		-		-		-135.8
Proceeds from exercise of stock options		7.2		-		-		-		7.2
Change in intercompany balances with affiliates, net		102.4		-157.2		54.8		-		-
Other		-0.4		-		-1.6		-		-2
Net cash (used in) provided by financing activities		-26.6		-157.2		53.2		-		-130.6
Change in cash and cash equivalents		-		-116.5		10.9		-		-105.6
Cash and cash equivalents at beginning of period		-		558.3		79.6		-		637.9
Cash and cash equivalents at end of period	$	-	$	441.8	$	90.5	$	-	$	532.3

Organization_Basis_Of_Presenta1

Organization, Basis Of Presentation And Accounting Standards Not Yet Adopted (Policy)	3 Months Ended
	Mar. 31, 2015
Organization, Basis Of Presentation And Accounting Standards Not Yet Adopted [Abstract]
Organization	Organization
	LifePoint Hospitals, Inc., a Delaware corporation, acting through its subsidiaries, operates general acute care hospitals primarily in non-urban communities in the United States (“U.S.”). Unless the context otherwise indicates, LifePoint Hospitals, Inc. and its subsidiaries are referred to herein as the “Company.” At March 31, 2015, on a consolidated basis, the Company operated 65 hospital campuses in 21 states.
Basis Of Presentation	Basis of Presentation
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, and disclosures considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.
	Additionally, the accompanying unaudited condensed consolidated financial statements include the accounts of the Company and all subsidiaries and entities controlled by the Company through its direct or indirect ownership of a majority interest and exclusive rights granted to the Company as the sole general partner or controlling member of such entities, including Duke LifePoint Healthcare, a joint venture between LifePoint and a wholly-controlled affiliate of Duke University Health System, Inc.  Furthermore, the Company consolidates any entities for which it receives the majority of the entity’s expected returns or is at risk for the majority of the entity’s expected losses based upon its investment or financial interest in the entity.  All significant intercompany accounts and transactions within the Company have been eliminated in consolidation.
Accounting Standards Not Yet Adopted	Accounting Standards Not Yet Adopted
	ASU 2015-2, “Consolidation”
	In February 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-2 “Consolidation” (“ASU 2015-2”).  ASU 2015-2 includes amendments that are intended to improve targeted areas of consolidation for legal entities including reducing the number of consolidation models from four to two and simplifying the FASB Accounting Standards Codification (“ASC”).  The provisions of ASU 2015-2 are effective for annual periods beginning after December 15, 2015.  The amendments may be applied retrospectively in previously issued financial statements for one or more years with a cumulative effect adjustment to retained earnings as of the beginning of the first year restated. Early adoption is permitted.  The Company is currently evaluating the impact that the adoption of ASU 2015-2 will have on its financial position, results of operation, cash flows and financial disclosures.
	ASU 2014-9, “Revenue from Contracts with Customers”
	In May 2014, the FASB issued ASU 2014-9, “Revenue from Contracts with Customers” (“ASU 2014-9”).  ASU 2014-9 provides for a single comprehensive principles-based standard for the recognition of revenue across all industries through the application of the following five-step process:
	Step 1: Identify the contract(s) with a customer.
	Step 2: Identify the performance obligations in the contract.
	Step 3: Determine the transaction price.
	Step 4: Allocate the transaction price to the performance obligations in the contract.
	Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
	Among other provisions and in addition to expanded disclosure about the nature, amount, timing and uncertainty of revenue, as well as certain additional quantitative and qualitative disclosures, ASU 2014-9 changes the healthcare industry specific presentation guidance under ASU 2011-7, “Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities.”  The provisions of ASU 2014-9 are effective for annual periods beginning after December 15, 2016, including interim periods within those years.    Early adoption is not permitted. The Company is currently evaluating the impact that the adoption of ASU 2014-9 will have on its revenue recognition policies and procedures, financial position, results of operations, cash flows, financial disclosures and control framework.

Revenue_Recognition_And_Accoun1

Revenue Recognition And Accounts Receivable (Tables)	3 Months Ended
	Mar. 31, 2015
Revenue Recognition And Accounts Receivable [Abstract]
Schedule Of Revenues By Payor And Approximate Percentages Of Revenues
		Three Months Ended March 31,
		2015				2014
				% of				% of
		Amount		Revenues		Amount		Revenues
	Medicare	$	377.9	29.9	%	$	316.8	31.5	%
	Medicaid		197.4	15.6			140.2	13.9
	HMOs, PPOs and other private insurers		681.1	53.9			536.6	53.2
	Self-pay		164.3	13.0			167.2	16.6
	Other		30.9	2.5			22.0	2.2
	Revenues before provision for doubtful accounts		1,451.6	114.9			1,182.8	117.4
	Provision for doubtful accounts		-187.9	-14.9			-175.6	-17.4
	Revenues	$	1,263.7	100.0	%	$	1,007.2	100.0	%
Schedule Of Allowance For Doubtful Accounts
	Balance at January 1, 2015	$	709.5
	Additions recognized as a reduction to revenues		187.9
	Accounts written off, net of recoveries		-189.3
	Balance at March 31, 2015	$	708.1

Fair_Value_Of_Financial_Instru1

Fair Value Of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2015
Fair Value Of Financial Instruments [Abstract]
Schedule Of Carrying Amount And Fair Value
		Carrying Amount				Fair Value
		March 31,		December 31,		March 31,		December 31,
		2015		2014		2015		2014
	Senior Credit Agreement:
	Term Facility	$	419.1	$	421.9	$	417.0	$	420.3
	Incremental Term Loans, excluding unamortized debt discount	$	222.6	$	222.6	$	222.6	$	222.0
	6.625% Senior Notes	$	400.0	$	400.0	$	420.5	$	422.0
	5.5% Senior Notes, excluding unamortized debt premium	$	1,100.0	$	1,100.0	$	1,152.3	$	1,130.3

Goodwill_And_Intangible_Assets1

Goodwill And Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2015
Goodwill And Intangible Assets [Abstract]
Schedule Of Intangible Assets
		March 31,		December 31,
		2015		2014
	Amortized intangible assets:
	Contract-based physician minimum revenue guarantees
	Gross carrying amount	$	59.9	$	62.3
	Accumulated amortization		-35.7		-35.5
	Net total		24.2		26.8
	Non-competition agreements and other
	Gross carrying amount		25.0		23.6
	Accumulated amortization		-16.8		-15.9
	Net total		8.2		7.7
	Total amortized intangible assets
	Gross carrying amount		84.9		85.9
	Accumulated amortization		-52.5		-51.4
	Net total		32.4		34.5
	Indefinite-lived intangible assets:
	Certificates of need and certificates of need exemptions		29.7		29.5
	Licenses, provider numbers, accreditations and other		9.6		5.1
	Net total		39.3		34.6
	Total intangible assets:
	Gross carrying amount		124.2		120.5
	Accumulated amortization		-52.5		-51.4
	Net total	$	71.7	$	69.1

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2015
Stock-Based Compensation [Abstract]
Schedule Of Estimates Of Weighted-Average Fair Value Per Share Of Stock Options Granted
		Three Months Ended March 31,
		2015				2014
	Expected volatility		29.0	%			29.0	%
	Risk-free interest rate, minimum		0.02	%			0.05	%
	Risk-free interest rate, maximum		1.96	%			2.71	%
	Expected dividends		-				-
	Average expected term (years)		5.3				5.4
	Fair value per share of stock options granted	$	18.65			$	13.95
Schedule Of Total Stock-Based Compensation Expense And Total Recognized Tax Benefits
		Three Months Ended
		March 31,
		2015			2014
	Equity awards:
	Other stock-based awards	$	4.7		$	4.3
	Stock options		2.9			2.4
			7.6			6.7
	Liability awards:
	Other stock-based awards		0.7			0.2
	Total stock-based compensation expense	$	8.3		$	6.9
	Tax benefit on stock-based compensation expense	$	3.3		$	2.7

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Computation Of Basic And Diluted Earnings Per Share
		Three Months Ended
		March 31,
		2015		2014
	Numerator for basic and diluted earnings per share attributable to
	LifePoint Hospitals, Inc.:
	Net income	$	42.0	$	37.7
	Less: Net income attributable to noncontrolling interests
	and redeemable noncontrolling interests		-3.1		-0.6
	Net income attributable to LifePoint Hospitals, Inc.	$	38.9	$	37.1
	Denominator:
	Weighted average shares outstanding - basic		44.1		45.9
	Effect of dilutive securities:
	Stock options and other stock-based awards		2.0		1.5
	Convertible debt instruments		-		0.4
	Weighted average shares outstanding - diluted		46.1		47.8
	Earnings per share attributable to LifePoint Hospitals, Inc. stockholders:
	Basic	$	0.88	$	0.81
	Diluted	$	0.84	$	0.78

Guarantor_And_NonGuarantor_Sup1

Guarantor And Non-Guarantor Supplementary Information (Tables)	3 Months Ended
	Mar. 31, 2015
Guarantor And Non-Guarantor Supplementary Information [Abstract]
Schedule Of Condensed Consolidating Statements Of Operations	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Operations
	For the Three Months Ended March 31, 2015
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Revenues before provision for
	doubtful accounts	$	-	$	835.0	$	616.6	$	-	$	1,451.6
	Provision for doubtful accounts		-		115.2		72.7		-		187.9
	Revenues		-		719.8		543.9		-		1,263.7
	Salaries and benefits		8.3		331.3		271.6		-		611.2
	Supplies		-		104.8		92.0		-		196.8
	Other operating expenses		-1.3		178.8		116.1		-		293.6
	Other income		-		-9.8		-1.9		-		-11.7
	Equity in earnings of affiliates		-59.5		-		-		59.5		-
	Depreciation and amortization		-		45.4		22.6		-		68.0
	Interest expense, net		8.6		16.4		3.4		-		28.4
	Impairment charges		-		11.6		-		-		11.6
	Management (income) fees		-		-8.5		8.5		-		-
			-43.9		670.0		512.3		59.5		1,197.9
	Income before income taxes		43.9		49.8		31.6		-59.5		65.8
	Provision for income taxes		5.0		18.8		-		-		23.8
	Net income		38.9		31.0		31.6		-59.5		42.0
	Less:  Net income attributable to
	noncontrolling interests and
	redeemable noncontrolling interests		-		-0.2		-2.9		-		-3.1
	Net income attributable to LifePoint
	Hospitals, Inc.	$	38.9	$	30.8	$	28.7	$	-59.5	$	38.9
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Operations
	For the Three Months Ended March 31, 2014
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Revenues before provision for
	doubtful accounts	$	-	$	838.0	$	344.8	$	-	$	1,182.8
	Provision for doubtful accounts		-		128.3		47.3		-		175.6
	Revenues		-		709.7		297.5		-		1,007.2
	Salaries and benefits		6.9		324.5		143.4		-		474.8
	Supplies		-		102.7		54.3		-		157.0
	Other operating expenses		-		180.7		62.8		-		243.5
	Other income		-		-13.6		-0.3		-		-13.9
	Equity in earnings of affiliates		-56.3		-		-		56.3		-
	Depreciation and amortization		-		45.3		15.8		-		61.1
	Interest expense, net		14.3		17.0		2.6		-		33.9
	Management (income) fees		-		-5.1		5.1		-		-
			-35.1		651.5		283.7		56.3		956.4
	Income before income taxes		35.1		58.2		13.8		-56.3		50.8
	(Benefit) provision for income taxes		-2		15.1		-		-		13.1
	Net income		37.1		43.1		13.8		-56.3		37.7
	Less:  Net income attributable to
	noncontrolling interests and
	redeemable noncontrolling interests		-		-0.2		-0.4		-		-0.6
	Net income attributable to LifePoint
	Hospitals, Inc.	$	37.1	$	42.9	$	13.4	$	-56.3	$	37.1
Schedule Of Condensed Consolidating Balance Sheets	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Balance Sheets
	31-Mar-15
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	ASSETS
	Current assets:
	Cash and cash equivalents	$	-	$	164.2	$	117.7	$	-	$	281.9
	Accounts receivable, net		-		453.6		293.9		-		747.5
	Inventories		-		70.9		43.2		-		114.1
	Prepaid expenses		-		31.0		17.8		-		48.8
	Income taxes receivable		25.0		-		-		-		25.0
	Deferred tax assets		64.4		-		-		-		64.4
	Other current assets		-		54.1		35.6		-		89.7
			89.4		773.8		508.2		-		1,371.4
	Property and equipment:
	Land		-		70.8		61.1		-		131.9
	Buildings and improvements		-		1,530.1		646.2		-		2,176.3
	Equipment		-		1,267.0		327.7		-		1,594.7
	Construction in progress		-		51.5		17.7		-		69.2
			-		2,919.4		1,052.7		-		3,972.1
	Accumulated depreciation		-		-1,406.00		-242.7		-		-1,648.70
			-		1,513.4		810.0		-		2,323.4
	Deferred loan costs, net		30.4		-		-		-		30.4
	Intangible assets, net		-		32.1		39.6		-		71.7
	Investments in subsidiaries		2,085.9		-		-		-2,085.90		-
	Due from subsidiaries		2,349.3		-		-		-2,349.30		-
	Other assets		7.2		20.0		34.0		-		61.2
	Goodwill		-		1,435.4		197.9		-		1,633.3
	Total assets	$	4,562.2	$	3,774.7	$	1,589.7	$	-4,435.20	$	5,491.4
	LIABILITIES AND EQUITY
	Current liabilities:
	Accounts payable	$	-	$	88.3	$	69.7	$	-	$	158.0
	Accrued salaries		-		97.7		72.2		-		169.9
	Other current liabilities		34.2		123.0		89.0		-		246.2
	Current maturities of long-term debt		19.7		0.9		1.4		-		22.0
			53.9		309.9		232.3		-		596.1
	Long-term debt		2,131.6		48.9		12.3		-		2,192.8
	Due to Parent		-		1,686.4		662.9		-2,349.30		-
	Deferred income tax liabilities		191.4		-		-		-		191.4
	Long-term portion of reserves for self-insurance claims		-		103.3		34.2		-		137.5
	Other long-term liabilities		10.2		25.8		46.1		-		82.1
	Total liabilities		2,387.1		2,174.3		987.8		-2,349.30		3,199.9
	Redeemable noncontrolling interests		-		-		89.2		-		89.2
	Total LifePoint Hospitals, Inc. stockholders' equity		2,175.1		1,598.9		487.0		-2,085.90		2,175.1
	Noncontrolling interests		-		1.5		25.7		-		27.2
	Total equity		2,175.1		1,600.4		512.7		-2,085.90		2,202.3
	Total liabilities and equity	$	4,562.2	$	3,774.7	$	1,589.7	$	-4,435.20	$	5,491.4
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Balance Sheets
	December 31, 2014
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	ASSETS
	Current assets:
	Cash and cash equivalents	$	-	$	62.0	$	129.5	$	-	$	191.5
	Accounts receivable, net		-		451.4		301.2		-		752.6
	Inventories		-		71.3		43.9		-		115.2
	Prepaid expenses		0.1		29.1		16.2		-		45.4
	Income taxes receivable		33.0		-		-		-		33.0
	Deferred tax assets		72.8		-		-		-		72.8
	Other current assets		-		53.5		32.2		-		85.7
		105.9		667.3		523.0		-		1,296.2
Property and equipment:
Land		-		70.0		64.8		-		134.8
Buildings and improvements		-		1,542.2		613.7		-		2,155.9
Equipment		-		1,289.9		343.9		-		1,633.8
Construction in progress		-		49.6		23.3		-		72.9
		-		2,951.7		1,045.7		-		3,997.4
Accumulated depreciation		-		-1,398.30		-221.6		-		-1,619.90
		-		1,553.4		824.1		-		2,377.5
Deferred loan costs, net		31.7		-		-		-		31.7
Intangible assets, net		-		34.6		34.5		-		69.1
Investments in subsidiaries		2,025.6		-		-		-2,025.60		-
Due from subsidiaries		2,352.1		-		-		-2,352.10		-
Other assets		6.6		19.4		20.4		-		46.4
Goodwill		-		1,440.5		195.6		-		1,636.1
Total assets	$	4,521.9	$	3,715.2	$	1,597.6	$	-4,377.70	$	5,457.0
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	-	$	90.4	$	68.1	$	-	$	158.5
Accrued salaries		-		130.9		71.5		-		202.4
Other current liabilities		14.5		112.7		76.0		-		203.2
Current maturities of long-term debt		16.9		0.9		1.4		-		19.2
		31.4		334.9		217.0		-		583.3
Long-term debt		2,137.5		49.1		12.7		-		2,199.3
Due to Parent		-		1,634.6		717.5		-2,352.10		-
Deferred income tax liabilities		187.5		-		-		-		187.5
Long-term portion of reserves for self-insurance claims		-		103.1		30.1		-		133.2
Other long-term liabilities		10.9		24.7		49.1		-		84.7
Total liabilities		2,367.3		2,146.4		1,026.4		-2,352.10		3,188.0
Redeemable noncontrolling interests		-		-		87.1		-		87.1
Total LifePoint Hospitals, Inc. stockholders' equity		2,154.6		1,567.0		458.6		-2,025.60		2,154.6
Noncontrolling interests		-		1.8		25.5		-		27.3
Total equity		2,154.6		1,568.8		484.1		-2,025.60		2,181.9
Total liabilities and equity	$	4,521.9	$	3,715.2	$	1,597.6	$	-4,377.70	$	5,457.0
Schedule Of Condensed Consolidating Statements Of Cash Flows	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Cash Flows
	For the Three Months Ended March 31, 2015
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Cash flows from operating activities:
	Net income	$	38.9	$	31.0	$	31.6	$	-59.5	$	42.0
	Adjustments to reconcile net income to net cash provided
	by operating activities:
	Equity in earnings of affiliates		-59.5		-		-		59.5		-
	Stock-based compensation		7.6		-		-		-		7.6
	Depreciation and amortization		-		45.4		22.6		-		68.0
	Amortization of physician minimum revenue guarantees		-		2.7		0.5		-		3.2
	Amortization of debt discounts, premium and deferred loan costs		1.2		-		-		-		1.2
	Impairment charges		-		11.6		-		-		11.6
	Deferred income taxes		12.3		-		-		-		12.3
	Reserve for self-insurance claims, net of payments		-		-		4.1		-		4.1
	Increase (decrease) in cash from operating assets and
	liabilities, net of effects of acquisitions and divestitures:
	Accounts receivable		-		-0.7		6.9		-		6.2
	Inventories, prepaid expenses and other current assets		0.1		19.7		-5.7		-		14.1
	Accounts payable, accrued salaries and other current liabilities		19.5		-27.5		12.0		-		4.0
	Income taxes payable/receivable		8.0		-		-		-		8.0
	Other		-0.7		-2.6		0.6		-		-2.7
	Net cash provided by operating activities		27.4		79.6		72.6		-		179.6
	Cash flows from investing activities:
	Purchases of property and equipment		-		-28.4		-12.7		-		-41.1
	Acquisitions, net of cash acquired		-		-4		-9.3		-		-13.3
	Other		-0.6		2.8		-2		-		0.2
	Net cash used in investing activities		-0.6		-29.6		-24		-		-54.2
	Cash flows from financing activities:
	Payments of borrowings		-2.8		-		-		-		-2.8
	Repurchases of common stock		-33.8		-		-		-		-33.8
	Proceeds from exercise of stock options		7.0		-		-		-		7.0
	Change in intercompany balances with affiliates, net		2.8		51.8		-54.6		-		-
	Other		-		0.4		-5.8		-		-5.4
	Net cash (used in) provided by financing activities		-26.8		52.2		-60.4		-		-35
	Change in cash and cash equivalents		-		102.2		-11.8		-		90.4
	Cash and cash equivalents at beginning of period		-		62.0		129.5		-		191.5
	Cash and cash equivalents at end of period	$	-	$	164.2	$	117.7	$	-	$	281.9
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Cash Flows
	For the Three Months Ended March 31, 2014
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Cash flows from operating activities:
	Net income	$	37.1	$	43.1	$	13.8	$	-56.3	$	37.7
	Adjustments to reconcile net income to net cash provided
	by operating activities:
	Equity in earnings of affiliates		-56.3		-		-		56.3		-
	Stock-based compensation		6.7		-		-		-		6.7
	Depreciation and amortization		-		45.3		15.8		-		61.1
	Amortization of physician minimum revenue guarantees		-		3.6		0.3		-		3.9
	Amortization of debt discounts and deferred loan costs		7.3		-		-		-		7.3
	Deferred income tax benefit		-41.6		-		-		-		-41.6
	Reserve for self-insurance claims, net of payments		-		3.3		2.8		-		6.1
	Increase (decrease) in cash from operating assets and
	liabilities, net of effects of acquisitions and divestitures:
	Accounts receivable		-		-32.2		-18.3		-		-50.5
	Inventories, prepaid expenses and other current assets		0.1		23.8		-0.8		-		23.1
	Accounts payable, accrued salaries and other current liabilities		21.7		-28.5		6.5		-		-0.3
	Income taxes payable/receivable		52.5		-		-		-		52.5
Other		-0.1		1.3		1.4		-		2.6
Net cash provided by operating activities		27.4		59.7		21.5		-		108.6
Cash flows from investing activities:
Purchases of property and equipment		-		-15.7		-6.8		-		-22.5
Acquisitions, net of cash acquired		-		-2.7		-57.9		-		-60.6
Other		-0.8		-0.6		0.9		-		-0.5
Net cash used in investing activities		-0.8		-19		-63.8		-		-83.6
Cash flows from financing activities:
Repurchases of common stock		-135.8		-		-		-		-135.8
Proceeds from exercise of stock options		7.2		-		-		-		7.2
Change in intercompany balances with affiliates, net		102.4		-157.2		54.8		-		-
Other		-0.4		-		-1.6		-		-2
Net cash (used in) provided by financing activities		-26.6		-157.2		53.2		-		-130.6
Change in cash and cash equivalents		-		-116.5		10.9		-		-105.6
Cash and cash equivalents at beginning of period		-		558.3		79.6		-		637.9
Cash and cash equivalents at end of period	$	-	$	441.8	$	90.5	$	-	$	532.3

Organization_Basis_Of_Presenta2

Organization, Basis Of Presentation And Recently Issued Accounting Pronouncment (Details)	Mar. 31, 2015
	state
	site
Organization, Basis Of Presentation And Accounting Standards Not Yet Adopted [Abstract]
Number of hospital campuses operated by company	65
Number of states in which the company operates	21

Revenue_Recognition_And_Accoun2

Revenue Recognition And Accounts Receivable (Narrative) (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Revenue Recognition And Accounts Receivable [Abstract]
Percent of gross accounts receivable for doubtful accounts	48.60%	48.50%
Percent of self-pay receivables for allowance for doubtful accounts	88.00%	88.40%

Revenue_Recognition_And_Accoun3

Revenue Recognition And Accounts Receivable (Schedule Of Revenues By Payor And Approximate Percentages Of Revenues) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Ratio of Revenues before provision for doubtful accounts	114.90%	117.40%
Ratio of Provision for doubtful accounts	-14.90%	-17.40%
Ratio of Net revenues	100.00%	100.00%
Revenues before provision for doubtful accounts	$1,451.60	$1,182.80
Provision for doubtful accounts	-187.9	-175.6
Revenues	1,263.70	1,007.20
Medicare [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Ratio of Revenues before provision for doubtful accounts	29.90%	31.50%
Revenues before provision for doubtful accounts	377.9	316.8
Medicaid [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Ratio of Revenues before provision for doubtful accounts	15.60%	13.90%
Revenues before provision for doubtful accounts	197.4	140.2
HMOs, PPOs And Other Private Insurers [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Ratio of Revenues before provision for doubtful accounts	53.90%	53.20%
Revenues before provision for doubtful accounts	681.1	536.6
Self-pay [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Ratio of Revenues before provision for doubtful accounts	13.00%	16.60%
Revenues before provision for doubtful accounts	164.3	167.2
Other Payors [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Ratio of Revenues before provision for doubtful accounts	2.50%	2.20%
Revenues before provision for doubtful accounts	$30.90	$22

Revenue_Recognition_And_Accoun4

Revenue Recognition And Accounts Receivable (Schedule Of Allowance For Doubtful Accounts) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Revenue Recognition And Accounts Receivable [Abstract]
Balance at January 1, 2015	$709.50
Provision for doubtful accounts	187.9	175.6
Accounts written off, net of recoveries	-189.3
Balance at March 31, 2015	$708.10

General_And_Administrative_Cos1

General And Administrative Costs (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Depreciation and amortization	$68	$61.10
Hospital Support Center [Member]
General and administrative included in corporate overhead costs	53.9	52.2
Depreciation and amortization	$8.10	$7.30

Fair_Value_Of_Financial_Instru2

Fair Value Of Financial Instruments (Narrative) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Warrants	8.5	$9.20
6.625% Senior Notes [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt instrument, stated interest rate	6.63%
Debt instrument, maturity date	1-Oct-20
5.5% Senior Notes [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt instrument, stated interest rate	5.50%
Debt instrument, maturity date	1-Dec-21

Fair_Value_Of_Financial_Instru3

Fair Value Of Financial Instruments (Carrying Amount And Fair Value Of Long-Term Debt Instruments) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Millions, unless otherwise specified
Term Facility [Member]
Debt Instrument [Line Items]
Carrying Amount	$419.10	$421.90
Fair Value	417	420.3
Incremental Term Loans [Member]
Debt Instrument [Line Items]
Carrying Amount	222.6	222.6
Fair Value	222.6	222
6.625% Senior Notes [Member]
Debt Instrument [Line Items]
Carrying Amount	400	400
Fair Value	420.5	422
Debt instrument, stated interest rate	6.63%
5.5% Senior Notes [Member]
Debt Instrument [Line Items]
Carrying Amount	1,100	1,100
Fair Value	$1,152.30	$1,130.30
Debt instrument, stated interest rate	5.50%

Acquisitions_Details

Acquisitions (Details) (USD $)	0 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Feb. 01, 2015	Mar. 31, 2015
Nason Hospital [Member]
Business Acquisition [Line Items]
Acquisition date	1-Feb-15
Number of beds in hospital	45
Cash paid for business acquisition	$3.50
Amounts committed to invest in capital expenditures and improvements subsequent to acquisition	8.5
Term for committed investment in capital expenditure and improvements, in years	10 years
Ancillary Service-Line Acquisitions [Member]
Business Acquisition [Line Items]
Cash paid for business acquisition		$9.80

Divestitures_And_Impairment_Ch1

Divestitures And Impairment Charges (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Putnam Community Medical Center [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued operation, operating income (loss)	$1.70	$2.40
Discontinued operation, other current assets	21.8
Discontinued operation, other current liabilities	2.4
Impairment charge	8.6
Income, net of income taxes	5.6
Loss per diluted share	($0.12)
Lakeland, Northwest And Russellville [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Impairment charge	3
Income, net of income taxes	$1.90
Loss per diluted share	($0.04)

Goodwill_And_Intangible_Assets2

Goodwill And Intangible Assets (Narrative) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Other current liabilities	246.2	$203.20
Physician Minimum Revenue Guarantees Liability [Member]
Finite-Lived Intangible Assets [Line Items]
Other current liabilities	9.3	$9.30
Physician Minimum Revenue Guarantees Liability [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Physician minimum revenue guarantee amortization period	4 years
Physician Minimum Revenue Guarantees Liability [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Physician minimum revenue guarantee amortization period	5 years

Goodwill_And_Intangible_Assets3

Goodwill And Intangible Assets (Schedule Of Intangible Assets) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Millions, unless otherwise specified
Goodwill And Intangible Assets [Line Items]
Accumulated amortization	($52.50)	($51.40)
Indefinite-lived intangible assets	39.3	34.6
Gross carrying amount	124.2	120.5
Intangible Assets, Net (Excluding Goodwill), Total	71.7	69.1
Physician Minimum Revenue Guarantees Liability [Member]
Goodwill And Intangible Assets [Line Items]
Gross carrying amount	59.9	62.3
Accumulated amortization	-35.7	-35.5
Net Total	24.2	26.8
Non-Competition Agreements And Other [Member]
Goodwill And Intangible Assets [Line Items]
Gross carrying amount	25	23.6
Accumulated amortization	-16.8	-15.9
Net Total	8.2	7.7
Total Amortized Intangible Assets [Member]
Goodwill And Intangible Assets [Line Items]
Gross carrying amount	84.9	85.9
Accumulated amortization	-52.5	-51.4
Net Total	32.4	34.5
Licenses, Provider Numbers, Accreditations And Other [Member]
Goodwill And Intangible Assets [Line Items]
Indefinite-lived intangible assets	9.6	5.1
Certificates Of Need And Certificates Of Need Exemptions [Member]
Goodwill And Intangible Assets [Line Items]
Indefinite-lived intangible assets	$29.70	$29.50

Common_Stock_In_Treasury_Detai

Common Stock In Treasury (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Equity, Class of Treasury Stock [Line Items]
Aggregate purchase price	$33.80
Vested shares redeemed under LTIP and MSPP	0.1	0.1
Aggregate price of vested shares redeemed under LTIP and MSPP	8.8	7.2
2011 Repurchase Plan [Member]
Equity, Class of Treasury Stock [Line Items]
Board of Directors authorized the shares repurchase	350
Total number of shares repurchased		2.4
Aggregate purchase price		128.6
Average purchase price per share for shares repurchased		$53.22
2014 Repurchase Plan [Member]
Equity, Class of Treasury Stock [Line Items]
Board of Directors authorized the shares repurchase	150
Total number of shares repurchased	0.4
Aggregate purchase price	25
Average purchase price per share for shares repurchased	$67.86
Remaining amount authorized to repurchase	$75

StockBased_Compensation_Narrat

Stock-Based Compensation (Narrative) (Details) (USD $)	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares vesting parameters	In addition to requiring continuing service of the employee, the percentage of these restricted stock units that are earned at the end of the performance period is determined based on the Company's three-year annualized total shareholder return relative to a peer group, Standard and Poor's Global Industry Classification Standard's Sub-industry: Health Care Facilities with over $500.0 million in revenues or its equivalent. For the performance-based restricted stock units granted during the three months ended March 31, 2015, the number of shares payable at the end of the three-year performance period ranges from 0% to 200% of the targeted units. For the performance-based restricted stock units granted during the three months ended March 31, 2014, the number of shares payable at the end of the three-year performance period ranges from 0% to 100% of the targeted units, with any portion of the award that exceeds 100% up to 200% of the targeted units settled in cash equal to the fair market value on the date certification of the level of performance is achieved.
Total intrinsic value of stock options exercised	$4.50	$2.70
Amount received in cash from stock option exercises	7	7.2
Total estimated unrecognized compensation costs	55.5
Expected weighted average period for recognition of unrecognized compensation cost (in years)	1 year 10 months 24 days
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Expiration period	10 years	10 years
Vesting percentage	33.30%
Performance period	3 years
Unrecognized compensation cost related to stock options	20.3
Expected weighted average period for recognition of unrecognized compensation cost (in years)	1 year 8 months 12 days
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Other stock based awards granted in period	145,000	236,000
Performance period	3 years	3 years
Other Stock-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years	3 years
Unrecognized compensation cost related to other stock-based awards	$35.20
Expected weighted average period for recognition of unrecognized compensation cost (in years)	2 years
Minimum [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year	1 year
Minimum [Member] | Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share award percentage	0.00%	0.00%
Cash award percentage		100.00%
Minimum [Member] | Other Stock-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year	1 year
Maximum [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years	3 years
Maximum [Member] | Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share award percentage	200.00%	100.00%
Cash award percentage		200.00%
Maximum [Member] | Other Stock-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years	3 years
2013 Long-Term Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted in period	816,750	712,950
Other stock based awards granted in period	256,216	341,155

StockBased_Compensation_Schedu

Stock-Based Compensation (Schedule Of Estimates Of Weighted-Average Fair Value Per Share Of Stock Options Granted) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Stock-Based Compensation [Abstract]
Expected volatility	29.00%	29.00%
Risk free interest rate (range), minimum	0.02%	0.05%
Risk free interest rate (range), maximum	1.96%	2.71%
Average expected term (years)	5 years 3 months 18 days	5 years 4 months 24 days
Fair value per share of stock options granted	$18.65	$13.95

StockBased_Compensation_Schedu1

Stock-Based Compensation (Schedule Of Total Stock-Based Compensation Expense And Total Recognized Tax Benefits) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$8.30	$6.90
Total stock-based compensation expense related to equity awards only	7.6	6.7
Tax benefit on stock-based compensation expense	3.3	2.7
Other Stock-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	4.7	4.3
Stock-based compensation expense related to cash portion of equity awards	0.7	0.2
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$2.90	$2.40

Commitments_And_Contingencies_

Commitments And Contingencies (Narrative) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
	item
Commitments And Contingencies [Line Items]
Period after which overpayments are deemed fraudulent	60 days
Number of sellers	2
Number of hospitals	2
Number of physicians	2
Physician recruiting agreement, additional advancement period	1 year
Maximum advance payment committed to physicians	$22.40
Physician minimum revenue guarantee liability	9.3
Uncompleted project costs included in construction in progress	69.2	72.9
Estimated cost to complete and equip construction in progress	107
Total remaining capital expenditure commitments	1,643.20
Marquette General [Member]
Commitments And Contingencies [Line Items]
Minimum net proceeds to seller	15
Fair value of potential obligation	$18
Minimum [Member]
Commitments And Contingencies [Line Items]
Physician recruiting agreement advancement, pro rata forgiven period	36 months
Maximum [Member]
Commitments And Contingencies [Line Items]
Physician recruiting agreement advancement, pro rata forgiven period	48 months

Earnings_Per_Share_Computation

Earnings Per Share (Computation Of Basic And Diluted Earnings Per Share) (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Earnings Per Share [Abstract]
Income from continuing operations	$42	$37.70
Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests	-3.1	-0.6
Net income attributable to LifePoint Hospitals, Inc.	$38.90	$37.10
Weighted average shares outstanding - basic	44.1	45.9
Effect of dilutive securities: stock options and other stock-based awards	2	1.5
Effect of dilutive securities: convertible debt instruments		0.4
Weighted average shares outstanding - diluted	46.1	47.8
Basic	$0.88	$0.81
Diluted	$0.84	$0.78

Guarantor_And_NonGuarantor_Sup2

Guarantor And Non-Guarantor Supplementary Information (Schedule Of Condensed Consolidating Statements Of Operations) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Condensed Income Statements, Captions [Line Items]
Revenues before provision for doubtful accounts	$1,451.60	$1,182.80
Provision for doubtful accounts	187.9	175.6
Revenues	1,263.70	1,007.20
Salaries and benefits	611.2	474.8
Supplies	196.8	157
Other operating expenses	293.6	243.5
Other income	-11.7	-13.9
Depreciation and amortization	68	61.1
Interest expense, net	28.4	33.9
Impairment charges	11.6
Operating expenses, total	1,197.90	956.4
Income before income taxes	65.8	50.8
(Benefit) provision for income taxes	23.8	13.1
Net income	42	37.7
Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests	-3.1	-0.6
Net income attributable to LifePoint Hospitals, Inc.	38.9	37.1
Eliminations [Member]
Condensed Income Statements, Captions [Line Items]
Equity in earnings of affiliates	59.5	56.3
Operating expenses, total	59.5	56.3
Income before income taxes	-59.5	-56.3
Net income	-59.5	-56.3
Net income attributable to LifePoint Hospitals, Inc.	-59.5	-56.3
Parent Issuer [Member]
Condensed Income Statements, Captions [Line Items]
Salaries and benefits	8.3	6.9
Other operating expenses	-1.3
Equity in earnings of affiliates	-59.5	-56.3
Interest expense, net	8.6	14.3
Operating expenses, total	-43.9	-35.1
Income before income taxes	43.9	35.1
(Benefit) provision for income taxes	5	-2
Net income	38.9	37.1
Net income attributable to LifePoint Hospitals, Inc.	38.9	37.1
Guarantors [Member]
Condensed Income Statements, Captions [Line Items]
Revenues before provision for doubtful accounts	835	838
Provision for doubtful accounts	115.2	128.3
Revenues	719.8	709.7
Salaries and benefits	331.3	324.5
Supplies	104.8	102.7
Other operating expenses	178.8	180.7
Other income	-9.8	-13.6
Depreciation and amortization	45.4	45.3
Interest expense, net	16.4	17
Impairment charges	11.6
Management (income) fees	-8.5	-5.1
Operating expenses, total	670	651.5
Income before income taxes	49.8	58.2
(Benefit) provision for income taxes	18.8	15.1
Net income	31	43.1
Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests	-0.2	-0.2
Net income attributable to LifePoint Hospitals, Inc.	30.8	42.9
Non-Guarantors [Member]
Condensed Income Statements, Captions [Line Items]
Revenues before provision for doubtful accounts	616.6	344.8
Provision for doubtful accounts	72.7	47.3
Revenues	543.9	297.5
Salaries and benefits	271.6	143.4
Supplies	92	54.3
Other operating expenses	116.1	62.8
Other income	-1.9	-0.3
Depreciation and amortization	22.6	15.8
Interest expense, net	3.4	2.6
Management (income) fees	8.5	5.1
Operating expenses, total	512.3	283.7
Income before income taxes	31.6	13.8
Net income	31.6	13.8
Less: Net income attributable to noncontrolling interests and redeemable noncontrolling interests	-2.9	-0.4
Net income attributable to LifePoint Hospitals, Inc.	$28.70	$13.40

Guarantor_And_NonGuarantor_Sup3

Guarantor And Non-Guarantor Supplementary Information (Schedule Of Condensed Consolidating Balance Sheets) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	$281.90	$191.50	$532.30	$637.90
Accounts receivable, net	747.5	752.6
Inventories	114.1	115.2
Prepaid expenses	48.8	45.4
Income taxes receivable	25	33
Deferred tax assets	64.4	72.8
Other current assets	89.7	85.7
Total current assets	1,371.40	1,296.20
Land	131.9	134.8
Buildings and improvements	2,176.30	2,155.90
Equipment	1,594.70	1,633.80
Construction in progress (estimated costs to complete and equip after March 31, 2015 is $107.0)	69.2	72.9
Property and equipment, gross	3,972.10	3,997.40
Accumulated depreciation	-1,648.70	-1,619.90
Property and equipment, net	2,323.40	2,377.50
Deferred loan costs, net	30.4	31.7
Intangible assets, net	71.7	69.1
Other assets	61.2	46.4
Goodwill	1,633.30	1,636.10
Total assets	5,491.40	5,457
Accounts payable	158	158.5
Accrued salaries	169.9	202.4
Other current liabilities	246.2	203.2
Current maturities of long-term debt	22	19.2
Total current liabilities	596.1	583.3
Long-term debt	2,192.80	2,199.30
Deferred income tax liabilities	191.4	187.5
Long-term portion of reserves for self-insurance claims	137.5	133.2
Other long-term liabilities	82.1	84.7
Total liabilities	3,199.90	3,188
Redeemable noncontrolling interests	89.2	87.1
Total LifePoint Hospitals, Inc. stockholders' equity	2,175.10	2,154.60
Noncontrolling interests	27.2	27.3
Total equity	2,202.30	2,181.90
Total liabilities and equity	5,491.40	5,457
Parent Issuer [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Prepaid expenses		0.1
Income taxes receivable	25	33
Deferred tax assets	64.4	72.8
Total current assets	89.4	105.9
Deferred loan costs, net	30.4	31.7
Investments in subsidiaries	2,085.90	2,025.60
Due from subsidiaries	2,349.30	2,352.10
Other assets	7.2	6.6
Total assets	4,562.20	4,521.90
Other current liabilities	34.2	14.5
Current maturities of long-term debt	19.7	16.9
Total current liabilities	53.9	31.4
Long-term debt	2,131.60	2,137.50
Deferred income tax liabilities	191.4	187.5
Other long-term liabilities	10.2	10.9
Total liabilities	2,387.10	2,367.30
Total LifePoint Hospitals, Inc. stockholders' equity	2,175.10	2,154.60
Total equity	2,175.10	2,154.60
Total liabilities and equity	4,562.20	4,521.90
Guarantors [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	164.2	62	441.8	558.3
Accounts receivable, net	453.6	451.4
Inventories	70.9	71.3
Prepaid expenses	31	29.1
Other current assets	54.1	53.5
Total current assets	773.8	667.3
Land	70.8	70
Buildings and improvements	1,530.10	1,542.20
Equipment	1,267	1,289.90
Construction in progress (estimated costs to complete and equip after March 31, 2015 is $107.0)	51.5	49.6
Property and equipment, gross	2,919.40	2,951.70
Accumulated depreciation	-1,406	-1,398.30
Property and equipment, net	1,513.40	1,553.40
Intangible assets, net	32.1	34.6
Other assets	20	19.4
Goodwill	1,435.40	1,440.50
Total assets	3,774.70	3,715.20
Accounts payable	88.3	90.4
Accrued salaries	97.7	130.9
Other current liabilities	123	112.7
Current maturities of long-term debt	0.9	0.9
Total current liabilities	309.9	334.9
Long-term debt	48.9	49.1
Intercompany	1,686.40	1,634.60
Long-term portion of reserves for self-insurance claims	103.3	103.1
Other long-term liabilities	25.8	24.7
Total liabilities	2,174.30	2,146.40
Total LifePoint Hospitals, Inc. stockholders' equity	1,598.90	1,567
Noncontrolling interests	1.5	1.8
Total equity	1,600.40	1,568.80
Total liabilities and equity	3,774.70	3,715.20
Non-Guarantors [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	117.7	129.5	90.5	79.6
Accounts receivable, net	293.9	301.2
Inventories	43.2	43.9
Prepaid expenses	17.8	16.2
Other current assets	35.6	32.2
Total current assets	508.2	523
Land	61.1	64.8
Buildings and improvements	646.2	613.7
Equipment	327.7	343.9
Construction in progress (estimated costs to complete and equip after March 31, 2015 is $107.0)	17.7	23.3
Property and equipment, gross	1,052.70	1,045.70
Accumulated depreciation	-242.7	-221.6
Property and equipment, net	810	824.1
Intangible assets, net	39.6	34.5
Other assets	34	20.4
Goodwill	197.9	195.6
Total assets	1,589.70	1,597.60
Accounts payable	69.7	68.1
Accrued salaries	72.2	71.5
Other current liabilities	89	76
Current maturities of long-term debt	1.4	1.4
Total current liabilities	232.3	217
Long-term debt	12.3	12.7
Intercompany	662.9	717.5
Long-term portion of reserves for self-insurance claims	34.2	30.1
Other long-term liabilities	46.1	49.1
Total liabilities	987.8	1,026.40
Redeemable noncontrolling interests	89.2	87.1
Total LifePoint Hospitals, Inc. stockholders' equity	487	458.6
Noncontrolling interests	25.7	25.5
Total equity	512.7	484.1
Total liabilities and equity	1,589.70	1,597.60
Eliminations [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Investments in subsidiaries	-2,085.90	-2,025.60
Due from subsidiaries	-2,349.30	-2,352.10
Total assets	-4,435.20	-4,377.70
Intercompany	-2,349.30	-2,352.10
Total liabilities	-2,349.30	-2,352.10
Total LifePoint Hospitals, Inc. stockholders' equity	-2,085.90	-2,025.60
Total equity	-2,085.90	-2,025.60
Total liabilities and equity	($4,435.20)	($4,377.70)

Guarantor_And_NonGuarantor_Sup4

Guarantor And Non-Guarantor Supplementary Information (Schedule Of Condensed Consolidating Statements Of Cash Flows) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Condensed Cash Flow Statements, Captions [Line Items]
Net income	$42	$37.70
Stock-based compensation	7.6	6.7
Depreciation and amortization	68	61.1
Amortization of physician minimum revenue guarantees	3.2	3.9
Amortization of debt discounts, premium and deferred loan costs	1.2	7.3
Impairment charges	11.6
Deferred income taxes (benefit)	12.3	-41.6
Reserve for self-insurance claims, net of payments	4.1	6.1
Accounts receivable	6.2	-50.5
Inventories, prepaid expenses and other current assets	14.1	23.1
Accounts payable, accrued salaries and other current liabilities	4	-0.3
Income taxes payable/receivable	8	52.5
Other	-2.7	2.6
Net cash provided by operating activities	179.6	108.6
Purchases of property and equipment	-41.1	-22.5
Acquisitions, net of cash acquired	-13.3	-60.6
Other	0.2	-0.5
Net cash used in investing activities	-54.2	-83.6
Payments of borrowings	-2.8
Repurchases of common stock	-33.8	-135.8
Proceeds from exercise of stock options	7	7.2
Other	-5.4	-2
Net cash (used in) provided by financing activities	-35	-130.6
Change in cash and cash equivalents	90.4	-105.6
Cash and cash equivalents at beginning of period	191.5	637.9
Cash and cash equivalents at end of period	281.9	532.3
Parent Issuer [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income	38.9	37.1
Equity in earnings of affiliates	-59.5	-56.3
Stock-based compensation	7.6	6.7
Amortization of debt discounts, premium and deferred loan costs	1.2	7.3
Deferred income taxes (benefit)	12.3	-41.6
Inventories, prepaid expenses and other current assets	0.1	0.1
Accounts payable, accrued salaries and other current liabilities	19.5	21.7
Income taxes payable/receivable	8	52.5
Other	-0.7	-0.1
Net cash provided by operating activities	27.4	27.4
Other	-0.6	-0.8
Net cash used in investing activities	-0.6	-0.8
Payments of borrowings	-2.8
Repurchases of common stock	-33.8	-135.8
Proceeds from exercise of stock options	7	7.2
Change in intercompany balances with affiliates, net	2.8	102.4
Other		-0.4
Net cash (used in) provided by financing activities	-26.8	-26.6
Guarantors [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income	31	43.1
Depreciation and amortization	45.4	45.3
Amortization of physician minimum revenue guarantees	2.7	3.6
Impairment charges	11.6
Reserve for self-insurance claims, net of payments		3.3
Accounts receivable	-0.7	-32.2
Inventories, prepaid expenses and other current assets	19.7	23.8
Accounts payable, accrued salaries and other current liabilities	-27.5	-28.5
Other	-2.6	1.3
Net cash provided by operating activities	79.6	59.7
Purchases of property and equipment	-28.4	-15.7
Acquisitions, net of cash acquired	-4	-2.7
Other	2.8	-0.6
Net cash used in investing activities	-29.6	-19
Change in intercompany balances with affiliates, net	51.8	-157.2
Other	0.4
Net cash (used in) provided by financing activities	52.2	-157.2
Change in cash and cash equivalents	102.2	-116.5
Cash and cash equivalents at beginning of period	62	558.3
Cash and cash equivalents at end of period	164.2	441.8
Non-Guarantors [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income	31.6	13.8
Depreciation and amortization	22.6	15.8
Amortization of physician minimum revenue guarantees	0.5	0.3
Reserve for self-insurance claims, net of payments	4.1	2.8
Accounts receivable	6.9	-18.3
Inventories, prepaid expenses and other current assets	-5.7	-0.8
Accounts payable, accrued salaries and other current liabilities	12	6.5
Other	0.6	1.4
Net cash provided by operating activities	72.6	21.5
Purchases of property and equipment	-12.7	-6.8
Acquisitions, net of cash acquired	-9.3	-57.9
Other	-2	0.9
Net cash used in investing activities	-24	-63.8
Change in intercompany balances with affiliates, net	-54.6	54.8
Other	-5.8	-1.6
Net cash (used in) provided by financing activities	-60.4	53.2
Change in cash and cash equivalents	-11.8	10.9
Cash and cash equivalents at beginning of period	129.5	79.6
Cash and cash equivalents at end of period	117.7	90.5
Eliminations [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income	-59.5	-56.3
Equity in earnings of affiliates	$59.50	$56.30